| (±)-Clopidogrel bisulfate |
|
|
|
|
|
|
|
99.39% |
| (Rac)-BX 048 |
|
|
|
|
|
|
|
|
| (Rac)-Clopidogrel hydrogen-d9 sulfate |
|
|
|
|
|
|
|
|
| (±)-Clopidogrel hydrochloride |
|
|
|
|
|
|
|
95.0% |
| (±)-Clopidogrel-d7 sulfate |
|
|
|
|
|
|
|
|
| (±)-Clopidogrel-d4 |
|
|
|
|
|
|
|
|
| 1’-Epi Gemcitabine hydrochloride-13C,15N2 |
|
|
|
|
|
|
|
|
| 2-(Phenylethynyl)-ATP ammonium |
|
|
|
|
|
|
|
|
| 2-MeS-ADP trisodium |
|
|
|
|
|
|
|
99.40% |
| 2-MeS-ATP |
|
|
|
|
|
|
|
|
| 2-MeSADP |
|
|
|
|
|
|
|
|
| 2-Methylthio-AMP |
|
|
|
|
|
|
|
98.94% |
| 2-Methylthio-AMP diTEA |
|
|
|
|
|
|
|
|
| 2-Methylthio-AMP sodium |
|
|
|
|
|
|
|
|
| 2-Thio-UTP |
|
|
|
|
|
|
|
|
| 2-Thio-UTP tetrasodium |
|
|
|
|
|
|
|
|
| 3-O-Methylquercetin tetraacetate |
|
|
|
|
|
|
|
|
| 4-Thiouridine 5′-triphosphate tetralithium |
|
|
|
|
|
|
|
87.53% |
| 4-Thiouridine 5′-triphosphate tetrasodium |
|
|
|
|
|
|
|
|
| 5'-TMPS |
|
|
|
|
|
|
|
|
| 5'-UMPS |
|
|
|
|
|
|
|
|
| 5-OMe-UDP |
|
|
|
|
|
|
|
|
| 8-Aminoadenine |
|
|
|
|
|
|
|
98.34% |
| Acid blue 129 |
|
|
|
|
|
|
|
|
| ACT-281959 |
|
|
|
|
|
|
|
|
| Adenosine 2',5'-diphosphate sodium |
|
|
|
|
|
|
|
99.0% |
| Adenosine 3'-phosphate 5'-phosphosulfate |
|
|
|
|
|
|
|
|
| Adenosine 3'-phosphate 5'-phosphosulfate lithium |
|
|
|
|
|
|
|
|
| Adenosine 3'-phosphate 5'-phosphosulfate lithium, hydrate |
|
|
|
|
|
|
|
|
| Adenosine 3'-phosphate 5'-phosphosulfate triethylamine |
|
|
|
|
|
|
|
|
| ADP receptor-IN-1 |
|
|
|
|
|
|
|
|
| ADP-β-S trilithium |
|
|
|
|
|
|
|
94.9% |
| ADP-β-S trisodium |
|
|
|
|
|
|
|
|
| Antiplatelet agent 1 |
|
|
|
|
|
|
|
|
| Antiplatelet agent 2 |
|
|
|
|
|
|
|
|
| Ap4C tetrasodium |
|
|
|
|
|
|
|
|
| AR-C118925XX |
|
|
|
|
|
|
|
98.86% |
| AR-C66096 |
|
|
|
|
|
|
|
|
| AR-C67085 |
|
|
|
|
|
|
|
|
| ATP-γ-S tetrasodium |
|
|
|
|
|
|
|
|
| ATPγS tetralithium salt |
|
|
|
|
|
|
|
94.31% |
| AZD1283 |
|
|
|
|
|
|
|
99.33% |
| Becondogrel |
|
|
|
|
|
|
|
99.39% |
| Blue FPG-A trisodium |
|
|
|
|
|
|
|
|
| BMS-884775 |
|
|
|
|
|
|
|
|
| BPTU |
|
|
|
|
|
|
|
99.67% |
| BX 667 |
|
|
|
|
|
|
|
|
| Cangrelor |
|
|
|
|
|
|
|
|
| Cangrelor tetrasodium |
|
|
|
|
|
|
|
99.96% |
| Cichoriin |
|
|
|
|
|
|
|
99.9% |
| Clopidogrel-13C,d3 sulfate |
|
|
|
|
|
|
|
|
| Diquafosol |
|
|
|
|
|
|
|
|
| Elinogrel |
|
|
|
|
|
|
|
98.29% |
| Elinogrel potassium |
|
|
|
|
|
|
|
|
| Evategrel |
|
|
|
|
|
|
|
|
| Gαq/11 protein-IN-2 |
|
|
|
|
|
|
|
|
| HDB-1 |
|
|
|
|
|
|
|
98.02% |
| HDL-16 |
|
|
|
|
|
|
|
99.19% |
| Leukotriene E4 |
|
|
|
|
|
|
|
99.80% |
| Leukotriene E4-d5 |
|
|
|
|
|
|
|
98.5% |
| MRS 2179 ammonium |
|
|
|
|
|
|
|
99.34% |
| MRS 2211 sodium hydrate |
|
|
|
|
|
|
|
97.9% |
| MRS 2578 |
|
|
|
|
|
|
|
99.50% |
| mrs 4062 TEA |
|
|
|
|
|
|
|
|
| MRS-2179 |
|
|
|
|
|
|
|
|
| MRS2179 tetrasodium |
|
|
|
|
|
|
|
|
| MRS2179 tetrasodium hydrate |
|
|
|
|
|
|
|
99.6% |
| MRS2279 |
|
|
|
|
|
|
|
|
| MRS2279 diammonium |
|
|
|
|
|
|
|
|
| MRS2298 |
|
|
|
|
|
|
|
|
| MRS2365 |
|
|
|
|
|
|
|
|
| MRS2365 trisodium |
|
|
|
|
|
|
|
99.8% |
| MRS2395 |
|
|
|
|
|
|
|
|
| MRS2496 |
|
|
|
|
|
|
|
|
| MRS2500 tetraammonium |
|
|
|
|
|
|
|
99.91% |
| MRS2567 |
|
|
|
|
|
|
|
|
| MRS2603 |
|
|
|
|
|
|
|
|
| MRS2690 |
|
|
|
|
|
|
|
|
| MRS2690 disodium |
|
|
|
|
|
|
|
|
| MRS2693 ammonium |
|
|
|
|
|
|
|
|
| MRS2693 trisodium |
|
|
|
|
|
|
|
|
| MRS2768 tetrasodium salt |
|
|
|
|
|
|
|
98.7% |
| MRS2905 trisodium |
|
|
|
|
|
|
|
|
| MRS2957 |
|
|
|
|
|
|
|
|
| MRS4608 |
|
|
|
|
|
|
|
|
| MRS4654 |
|
|
|
|
|
|
|
|
| MRS4738 |
|
|
|
|
|
|
|
|
| MRS4833 |
|
|
|
|
|
|
|
|
| MRS4865 |
|
|
|
|
|
|
|
|
| MRS4917 |
|
|
|
|
|
|
|
|
| N6-(4-Hydroxybenzyl)adenosine |
|
|
|
|
|
|
|
99.84% |
| NF157 |
|
|
|
|
|
|
|
99.13% |
| NF340 |
|
|
|
|
|
|
|
|
| NF546 |
|
|
|
|
|
|
|
|
| NF546 hydrate |
|
|
|
|
|
|
|
97.4% |
| NSC380324 |
|
|
|
|
|
|
|
|
| P1,P2-Diuridine-5’-diphosphate |
|
|
|
|
|
|
|
|
| P2RY1 Human Pre-designed siRNA Set A |
|
|
|
|
|
|
|
|
| P2ry1 Mouse Pre-designed siRNA Set A |
|
|
|
|
|
|
|
|
| P2ry1 Rat Pre-designed siRNA Set A |
|
|
|
|
|
|
|
|
| P2RY12 Human Pre-designed siRNA Set A |
|
|
|
|
|
|
|
|
| P2ry12 Mouse Pre-designed siRNA Set A |
|
|
|
|
|
|
|
|
| P2ry12 Rat Pre-designed siRNA Set A |
|
|
|
|
|
|
|
|
| P2RY13 Human Pre-designed siRNA Set A |
|
|
|
|
|
|
|
|
| P2ry13 Mouse Pre-designed siRNA Set A |
|
|
|
|
|
|
|
|
| P2ry13 Rat Pre-designed siRNA Set A |
|
|
|
|
|
|
|
|
| P2RY14 Human Pre-designed siRNA Set A |
|
|
|
|
|
|
|
|
| P2ry14 Mouse Pre-designed siRNA Set A |
|
|
|
|
|
|
|
|
| P2ry14 Rat Pre-designed siRNA Set A |
|
|
|
|
|
|
|
|
| P2RY2 Human Pre-designed siRNA Set A |
|
|
|
|
|
|
|
|
| P2ry2 Mouse Pre-designed siRNA Set A |
|
|
|
|
|
|
|
|
| P2ry2 Rat Pre-designed siRNA Set A |
|
|
|
|
|
|
|
|
| P2RY4 Human Pre-designed siRNA Set A |
|
|
|
|
|
|
|
|
| P2ry4 Mouse Pre-designed siRNA Set A |
|
|
|
|
|
|
|
|
| P2ry4 Rat Pre-designed siRNA Set A |
|
|
|
|
|
|
|
|
| P2Y1 antagonist 1 |
|
|
|
|
|
|
|
|
| P2Y1 antagonist 2 |
|
|
|
|
|
|
|
|
| P2Y1 antagonist 3 |
|
|
|
|
|
|
|
|
| P2Y1 antagonist 4 |
|
|
|
|
|
|
|
|
| P2Y1 antagonist 6 |
|
|
|
|
|
|
|
|
| P2Y1/P2Y12 antagonist-1 |
|
|
|
|
|
|
|
99.87% |
| P2Y1/P2Y6 antagonist 1 |
|
|
|
|
|
|
|
|
| P2Y12 antagonist 1 |
|
|
|
|
|
|
|
|
| P2Y12 antagonist 2 |
|
|
|
|
|
|
|
|
| P2Y12/PDE5-IN-1 |
|
|
|
|
|
|
|
|
| P2Y12R ligand-1 |
|
|
|
|
|
|
|
|
| P2Y14 antagonist 1 |
|
|
|
|
|
|
|
|
| P2Y14R antagonist 1 |
|
|
|
|
|
|
|
98.76% |
| P2Y14R antagonist 2 |
|
|
|
|
|
|
|
99.56% |
| P2Y14R antagonist 3 |
|
|
|
|
|
|
|
|
| P2Y14R antagonist 4 |
|
|
|
|
|
|
|
|
| P2Y2R antagonist 1 |
|
|
|
|
|
|
|
|
| P2Y2R/GPR17 antagonist 1 |
|
|
|
|
|
|
|
98.09% |
| P2Y6R antagonist 1 |
|
|
|
|
|
|
|
99.94% |
| PIT |
|
|
|
|
|
|
|
99.07% |
| PPTN |
|
|
|
|
|
|
|
99.63% |
| PPTN hydrochloride |
|
|
|
|
|
|
|
99.89% |
| PPTN mesylate |
|
|
|
|
|
|
|
|
| Prasugrel hydroxy thiolactone |
|
|
|
|
|
|
|
|
| PSB 0474 |
|
|
|
|
|
|
|
|
| PSB-0739 |
|
|
|
|
|
|
|
98.0% |
| PSB-1114 tetrasodium |
|
|
|
|
|
|
|
|
| PSB-1114 triethylamine |
|
|
|
|
|
|
|
|
| PSB-16133 sodium |
|
|
|
|
|
|
|
99.17% |
| PSB-22219 |
|
|
|
|
|
|
|
|
| R-138727 |
|
|
|
|
|
|
|
|
| Regrelor disodium |
|
|
|
|
|
|
|
99.89% |
| Rp-dUTPαS tetrasodium |
|
|
|
|
|
|
|
|
| Rp-UTP-α-S tetrasodium |
|
|
|
|
|
|
|
|
| SAR216471 |
|
|
|
|
|
|
|
|
| SAR216471 hydrochloride |
|
|
|
|
|
|
|
|
| Selatogrel |
|
|
|
|
|
|
|
99.75% |
| Selatogrel hydrochloride |
|
|
|
|
|
|
|
|
| Sodium metatungstate |
|
|
|
|
|
|
|
93.4% |
| Sp-ATPαS |
|
|
|
|
|
|
|
|
| Sp-ATPαS tetrasodium solution (100mM) |
|
|
|
|
|
|
|
98.60% |
| Sp-UTP-α-S |
|
|
|
|
|
|
|
|
| Sp-UTP-α-S tetrasodium |
|
|
|
|
|
|
|
|
| TAK-024 |
|
|
|
|
|
|
|
|
| TNP-ATP tetrasodium |
|
|
|
|
|
|
|
|
| trans-R-138727 |
|
|
|
|
|
|
|
98.98% |
| UDP-Galactose |
|
|
|
|
|
|
|
|
| UDP-GlcNAc |
|
|
|
|
|
|
|
|
| UDP-Galactose disodium |
|
|
|
|
|
|
|
99.73% |
| UMP-CP trisodium |
|
|
|
|
|
|
|
|
| Uridine 5'-diphosphate-13C9 dilithium |
|
|
|
|
|
|
|
|
| Uridine 5'-diphosphate-15N2 dilithium |
|
|
|
|
|
|
|
|
| Uridine 5′-diphosphoglucose |
|
|
|
|
|
|
|
|
| Uridine 5′-diphosphoglucose (Standard) |
|
|
|
|
|
|
|
99.59% |
| Uridine 5′-diphosphoglucose-13C disodium |
|
|
|
|
|
|
|
98.8% |
| Uridine 5′-diphosphoglucose-13C6 disodium |
|
|
|
|
|
|
|
98.35% |
| Uridine 5'-O-thiodiphosphate |
|
|
|
|
|
|
|
|
| Uridine 5'-O-thiodiphosphate trisodium |
|
|
|
|
|
|
|
|
| Uridine-5'-O-3-thiotriphosphate |
|
|
|
|
|
|
|
|
| Uridine-5'-O-3-thiotriphosphate tetrasodium |
|
|
|
|
|
|
|
|
| Uridine-5'-O-3-thiotriphosphate trisodium |
|
|
|
|
|
|
|
|
| UTPU trisodium |
|
|
|
|
|
|
|
|
| YM-254890 |
|
|
|
|
|
|
|
99.18% |
| YM-254891 |
|
|
|
|
|
|
|
|
| Uridine 5′-diphosphoglucose disodium |
|
|
|
|
|
|
|
99.98% |
| Diquafosol tetrasodium |
|
|
|
|
|
|
|
99.0% |
| Uridine 5'-diphosphate |
|
|
|
|
|
|
|
|
| Uridine 5'-diphosphate-13C9,15N2 dilithium |
|
|
|
|
|
|
|
99.15% |
| Uridine-5'-diphosphate disodium salt |
|
|
|
|
|
|
|
99.61% |
| Uridine 5'-diphosphate sodium salt |
|
|
|
|
|
|
|
98.0% |
| UTP trisodium salt, 100 mM Solution, PCR Grade |
|
|
|
|
|
|
|
|
| Uridine triphosphate |
|
|
|
|
|
|
|
|
| Uridine triphosphate trisodium salt |
|
|
|
|
|
|
|
96.0% |
| Desmodilactone |
|
|
|
|
|
|
|
|
| Prasugrel |
|
|
|
|
|
|
|
99.75% |
| Prasugrel-d3 |
|
|
|
|
|
|
|
98.58% |
| Prasugrel-13C6 |
|
|
|
|
|
|
|
|
| Prasugrel-d4 |
|
|
|
|
|
|
|
|
| Prasugrel-d5 |
|
|
|
|
|
|
|
|
| Ticagrelor-d7 |
|
|
|
|
|
|
|
|
| Ticagrelor-d4 |
|
|
|
|
|
|
|
|
| Ticagrelor |
|
|
|
|
|
|
|
99.95% |
| Clopidogrel-related Compound B hydrochloride |
|
|
|
|
|
|
|
99.67% |
| Clopidogrel |
|
|
|
|
|
|
|
98.43% |
| Clopidogrel thiolactone |
|
|
|
|
|
|
|
98.0% |
| Chloramphenicol succinate sodium |
|
|
|
|
|
|
|
97.17% |
| Chloramphenicol succinate |
|
|
|
|
|
|
|
|
| Prasugrel hydrochloride |
|
|
|
|
|
|
|
98.49% |
| Clopidogrel hydrogen sulfate |
|
|
|
|
|
|
|
99.88% |
| Clopidogrel-d3 hydrogen sulfate |
|
|
|
|
|
|
|
|
| Vicagrel |
|
|
|
|
|
|
|
99.92% |
| Meseclazone |
|
|
|
|
|
|
|
|
| Prasugrel (Maleic acid) |
|
|
|
|
|
|
|
|